Rubicon Organics Inc
Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in jar, bag, pre-rolls, edible, poutine sauce mix, milled flower, soft gels, hash, blunt, gummies, flower variety pack, pot brownies, resin vape, relief stick, coo… Read more
Rubicon Organics Inc (ROMJF) - Net Assets
Latest net assets as of September 2025: $46.13 Million USD
Based on the latest financial reports, Rubicon Organics Inc (ROMJF) has net assets worth $46.13 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($65.58 Million) and total liabilities ($19.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $46.13 Million |
| % of Total Assets | 70.33% |
| Annual Growth Rate | 15.19% |
| 5-Year Change | 29.68% |
| 10-Year Change | N/A |
| Growth Volatility | 23.99 |
Rubicon Organics Inc - Net Assets Trend (2016–2024)
This chart illustrates how Rubicon Organics Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rubicon Organics Inc (2016–2024)
The table below shows the annual net assets of Rubicon Organics Inc from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $37.40 Million | -1.30% |
| 2023-12-31 | $37.89 Million | -1.14% |
| 2022-12-31 | $38.33 Million | -1.46% |
| 2021-12-31 | $38.90 Million | +34.87% |
| 2020-12-31 | $28.84 Million | +55.77% |
| 2019-12-31 | $18.52 Million | -16.07% |
| 2018-12-31 | $22.06 Million | +32.20% |
| 2017-12-31 | $16.69 Million | +38.31% |
| 2016-12-31 | $12.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rubicon Organics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2797.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $131.49 Million | 351.55% |
| Total Equity | $37.40 Million | 100.00% |
Rubicon Organics Inc Competitors by Market Cap
The table below lists competitors of Rubicon Organics Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
$14.79 Million |
|
Ewein Bhd
KLSE:7249
|
$14.79 Million |
|
Hannet Co. Ltd
KQ:052600
|
$14.79 Million |
|
Bookook Steel
KO:026940
|
$14.79 Million |
|
Rana Sugars Limited
NSE:RANASUG
|
$14.78 Million |
|
Jindalee Lithium Ltd
AU:JLL
|
$14.78 Million |
|
ALFORMER Industrial Co. Ltd.
TWO:4558
|
$14.75 Million |
|
PT Pelayaran Tamarin Samudra Tbk
JK:TAMU
|
$14.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rubicon Organics Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 37,894,318 to 37,402,161, a change of -492,157 (-1.3%).
- Net loss of 2,562,406 reduced equity.
- Other factors increased equity by 2,070,249.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.56 Million | -6.85% |
| Other Changes | $2.07 Million | +5.54% |
| Total Change | $- | -1.30% |
Book Value vs Market Value Analysis
This analysis compares Rubicon Organics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.57x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.84x to 0.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.45 | $0.38 | x |
| 2018-12-31 | $0.60 | $0.38 | x |
| 2019-12-31 | $0.46 | $0.38 | x |
| 2020-12-31 | $0.58 | $0.38 | x |
| 2021-12-31 | $0.69 | $0.38 | x |
| 2022-12-31 | $0.68 | $0.38 | x |
| 2023-12-31 | $0.67 | $0.38 | x |
| 2024-12-31 | $0.66 | $0.38 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rubicon Organics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.26%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 1.51x
- Recent ROE (-6.85%) is above the historical average (-38.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 15.26% | 99.68% | 0.14x | 1.08x | $634.17K |
| 2017 | -35.06% | -661.55% | 0.04x | 1.31x | $-7.52 Million |
| 2018 | -135.42% | -1472.44% | 0.07x | 1.28x | $-32.08 Million |
| 2019 | -77.09% | -3143.71% | 0.01x | 2.15x | $-16.13 Million |
| 2020 | -51.95% | -159.61% | 0.18x | 1.77x | $-17.87 Million |
| 2021 | -37.33% | -64.22% | 0.41x | 1.41x | $-18.41 Million |
| 2022 | -10.06% | -10.86% | 0.63x | 1.46x | $-7.69 Million |
| 2023 | -4.81% | -4.55% | 0.73x | 1.45x | $-5.61 Million |
| 2024 | -6.85% | -5.26% | 0.86x | 1.51x | $-6.30 Million |
Industry Comparison
This section compares Rubicon Organics Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rubicon Organics Inc (ROMJF) | $46.13 Million | 15.26% | 0.42x | $14.78 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |